In Stock

Coviself

Email sales@platinum-medi.com for order

Minimum Order Quantity 100 pcs

Category:

Reviews

There are no reviews yet.

Be the first to review “Coviself”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsCoviself removeProduct: Rapid Diagnostic Tests For Malaria removeCovirat remove
Image
SKU
Rating
Price
Stock
Availability
Add to cart

Read more

Read more

Read more

DescriptionEmail sales@platinum-medi.com for order

Minimum Order Quantity 100 pcs

Product: Rapid Diagnostic Tests For Malaria Brand: Egens Packing: 25 set per box, 80 boxes per carton. 40 HQ container: can load 550 cartons ( 1.1 million sets ) Delivery Date:5-6 months ( for  6.59 million sets ) Download CertificatesEmail sales@platinum-medi.com for order

Minimum Order Quantity 100 pcs

In comparison with RT-PCR confirmed specimen

Sensitivity Specificity
Evaluation in USA 96.3% 100 %
Evaluation in India (RT-PCR positive specimens with Ct<30) 95.4% 96.36%
Content

CoviRAT

Rapid Test for Detection of SARS-CoV-2 Antigen in Human Nasopharyngeal Swab Specimens

CoviRAT is an in­vitro, rapid, qualitative immunoassay for the detection of nucleocapsid protein antigens expressed by the SARS­CoV­2 virus present in human nasopharyngeal swab specimen. It is to be used for screening or to aid in the diagnosis of COVID­19 and takes 15­30 minutes for producing test result. Rapid antigen tests are known to be sensitive enough to detect clinical cases, i.e. presymptomatic and early symptomatic cases (up to five days from symptom onset; or low RT­PCR cycle threshold (Ct) value <30), which likely account for a significant proportion of transmissions. The use of sensitive and specific rapid antigen test is appropriate in high prevalence areas as well as in low prevalence areas to identify the infectious positive cases. Rapid antigen tests can help reduce further transmission through early identification of positive cases, enabling a faster contact tracing
FEATURES BENEFITS
Double Antibody Sandwich Assay. Detects nucleocapsid protein antigens expressed by SARS­CoV­2 virus.
Monoclonal antibodies used in both capture and tracer part. Detects nucleocapsid protein antigens expressed by SARS­CoV­2 virus.
Nasopharyngeal specimen can be used. Facilitates higher volume testing at the patient site and in laboratory setup.
Rapid Antigen Detection Test. Results in 15­30 minutes.
Sterile Breakable nasopharyngeal swabs Minimizes exposure. Ease of use.
Sensitivity 96.3%* Specificity 100% Highly Sensitive and Accurate test result ; compared to RT­PCR !
Weight
DimensionsN/AN/AN/A
Additional information